Multiple Myeloma Clinical Targeted Sequencing of Patient Samples
Demographics (2)
- SEX - Biological sex (phv00558694.v1.p1)
- SEX - Biological sex (phv00558684.v1.p1)
Disease Events (2)
- DISEASE - Disease type (phv00558691.v1.p1)
- STAGE - Disease stage (phv00558692.v1.p1)
General Health (1)
- BODY_SITE - Body site where sample was collected (phv00558702.v1.p1)
Other (19)
- ANALYTE_TYPE - Analyte Type (phv00558703.v1.p1)
- BCMA_TREATED - Treatment information (phv00558697.v1.p1)
- CD138_STATUS - CD138 positive or negative (phv00558705.v1.p1)
- CD38_TREATED - Treatment information (phv00558698.v1.p1)
- CHEMOTHERAPY - Treatment information (phv00558696.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00558683.v1.p1)
- IMiD - Treatment information (phv00558699.v1.p1)
- IS_TUMOR - Tumor status (phv00558704.v1.p1)
- PROTEASOME_INHIBITOR - Treatment information (phv00558700.v1.p1)
- SAMPLE_ID - Sample ID (phv00558701.v1.p1)
- SAMPLE_ID - Sample ID (phv00558688.v1.p1)
- SAMPLE_PURITY - Flow cell sample purity (phv00558695.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00558686.v1.p1)
- SUBJECT_ID - Subject ID (phv00558689.v1.p1)
- SUBJECT_ID - Subject ID (phv00558682.v1.p1)
- SUBJECT_ID - Subject ID (phv00558687.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00558685.v1.p1)
- TIME_POINT - Saple collection time point (phv00558690.v1.p1)
- TREATMENT - Treatment information (phv00558693.v1.p1)